Schedule & Agenda

Below is the 2021 schedule and agenda for the BIO CEO & Investor Conference.
BIO CEO & Investor Digital Conference
Available On-Demand

3T Biosciences is an immunotherapy company based in South San Francisco. The…

Alphageneron is a clinical stage Cell therapy company with both autologoius NK Cell therapy…

Aruvant Sciences, part of the Roivant family of companies, is a clinical-stage biopharmaceutical…

Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic…

Kodikaz is a non-viral gene therapy platform company that has the unique technology ability of…

Likarda is a cell therapy and delivery company.
Likarda's foundational technology is based on…

MaxCyte is a clinical-stage global cell-based therapies and life sciences company. As the inventors…

Mogrify’s mission is to transform the development of ex vivo cell therapies and pioneer the field…

Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing…

Orchard Therapeutics is a global gene therapy leader dedicated to transforming the lives of people…

ORYZON is a public clinical stage biopharmaceutical company and the European leader in the…

Virica pioneered a new product category of Viral Sensitizers (VSE™) that removes the barriers to…

XyloCor Therapeutics is focused on the development of novel gene therapy for unmet needs in…